MedPath

A comparative study of upper limb function and cost effectiveness after collagenase injection and aponeurectomy for Dupuytren contracture

Not Applicable
Conditions
Dupuytren contracture
Registration Number
JPRN-UMIN000029826
Lead Sponsor
agoya University
Brief Summary

Participants comprised 52 patients in the Collagenase group and 26 patients in the Surgery group. Hand10 score was significantly better in the Collagenase group at 1 and 2 weeks. EQ-5D-5L score was significantly higher in the Collagenase group at 8 weeks. Mean direct cost was 248,000 yen higher in the Surgery group than in the Collagenase group.

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
78
Inclusion Criteria

Not provided

Exclusion Criteria

1) Patients who had treated Dupuytran contracture in the past and recurred 2) Patients with a history of hypersensitivity to components of injectable collagenase 3) Patients who may be pregnant or pregnant, patients wishing for pregnancy during this clinical study or patients who may be pregnant, lactating patients 4) Patients who are receiving anticoagulant, antiplatelet drug (excluding aspirin at 150 mg / day or less) within 7 days before treatment 5) Patients who are separately participating in intervention tests such as trials and clinical trials 6) Patients who have difficulty understanding and answering inquiries of documents consent in Japanese, 7) Other Research Responsibilities (Sharing) Patients judged inappropriate for doctors to conduct this clinical study

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath